Goldman Sachs
LABU icon

Goldman Sachs’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Goldman Sachs’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Sell
58,634
-42,342
-42% -$8.1M ﹤0.01% 2795
2026
Q1 		$16.8M Buy
100,976
+31,693
+46% +$5.2M ﹤0.01% 2602
2025
Q4 		$11M Sell
69,283
-16,028
-19% -$2.2M ﹤0.01% 3001
2025
Q3 		$7.99M Buy
85,311
+35,237
+70% +$2.49M ﹤0.01% 3192
2025
Q2 		$2.85M Sell
50,074
-1
-0% -$53 ﹤0.01% 3902
2025
Q1 		$3.05M Hold
50,075
– – ﹤0.01% 3820
2024
Q4 		$4.51M Sell
50,075
-4
-0% -$471 ﹤0.01% 3548
2024
Q3 		$6.45M Sell
50,079
-19
-0% -$2.48K ﹤0.01% 3123
2024
Q2 		$5.68M Buy
+50,098
New +$5.36M ﹤0.01% 3034
2024
Q1 		– Sell
-9,741
Closed -$1.19M – 5738
2023
Q4 		$1.19M Buy
+9,741
New +$745K ﹤0.01% 4287
2023
Q3 		– Sell
-843
Closed -$99.8K – 5725
2023
Q2 		$99.8K Buy
+843
New +$105K ﹤0.01% 5356
2023
Q1 		– Sell
-2,132
Closed -$301K – 6101
2022
Q4 		$301K Buy
+2,132
New +$297K ﹤0.01% 5144
2022
Q3 		– Sell
-550
Closed -$74K – 6423
2022
Q2 		$74K Buy
+550
New +$93.7K ﹤0.01% 5940
2019
Q3 		– Sell
-430
Closed -$432K – 5288
2019
Q2 		$432K Buy
+430
New +$416K ﹤0.01% 4460

Other funds holding LABU

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs's LABU Position: Q2 2026 in Review

Goldman Sachs reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 42% in Q2 2026, selling an estimated $8.1M and leaving 58,634 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2795.

Goldman Sachs first reported a position in LABU in Q2 2019 and has held it in 14 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Goldman Sachs held 58,634 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $17.1M as of Q2 2026.
  • Goldman Sachs sold 42,342 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $8.1M.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2795 holding.
  • Goldman Sachs first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2019 and has held it in 14 quarters since.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.